Literature DB >> 20356901

A role for STAT3 and cathepsin S in IL-10 down-regulation of IFN-gamma-induced MHC class II molecule on primary human blood macrophages.

Lally L Y Chan1, Benny K W Cheung, James C B Li, Allan S Y Lau.   

Abstract

IL-10, a potent anti-inflammatory cytokine, activates its primary mediator STAT3 to exert inhibitory effects on activated immune response. It has been reported that IFN-gamma signaling can be suppressed by IL-10, which deactivates macrophages and suppresses cell-mediated antigen presentation. Cathepsin S, a cysteine protease, plays a significant role in the antigen processing. We hypothesize that the IL-10-induced and STAT3-mediated signaling pathway interferes with IFN-gamma-induced immune responses in primary human blood macrophages. Here, we investigated whether IL-10 perturbs MHC-II levels via its effect on cathepsin S expression in antigen processing. We showed that the expression of cathepsin S and MHC-II, inducible by IFN-gamma, was down-regulated in the presence of IL-10. Additionally, we revealed that the inhibitory effect of IL-10 was demonstrated to be independent of the classical IFN-gamma-induced JAK2/STAT1 signaling cascade or the NF-kappaB pathway. Following STAT3 suppression with specific siRNA, the expression of IFN-gamma-induced surface MHC-II antigens and cathepsin S levels was restored, even in the presence of IL-10. Taken together, our results demonstrated that the immunosuppressive effects of IL-10-STAT3 on MHC-II antigen presentation may occur via the inhibition of cathepsin S expression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20356901     DOI: 10.1189/jlb.1009659

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  29 in total

1.  Contribution of a TANK-binding kinase 1-interferon (IFN) regulatory factor 7 pathway to IFN-γ-induced gene expression.

Authors:  Matthias Farlik; Birgit Rapp; Isabelle Marie; David E Levy; Amanda M Jamieson; Thomas Decker
Journal:  Mol Cell Biol       Date:  2012-01-17       Impact factor: 4.272

Review 2.  IFN-γ: A cytokine at the right time, is in the right place.

Authors:  J Daniel Burke; Howard A Young
Journal:  Semin Immunol       Date:  2019-06-17       Impact factor: 11.130

Review 3.  Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells.

Authors:  Srinivas Nagaraj; Dmitry I Gabrilovich
Journal:  Semin Cancer Biol       Date:  2012-01-31       Impact factor: 15.707

4.  A role for interleukin-17A in modulating intracellular survival of Mycobacterium bovis bacillus Calmette-Guérin in murine macrophages.

Authors:  Wai Lim Ling; Liang Jie Wang; John C H Pong; Allan S Y Lau; James C B Li
Journal:  Immunology       Date:  2013-11       Impact factor: 7.397

5.  Antigen-specific CD4(+) T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling.

Authors:  Srinivas Nagaraj; Allison Nelson; Je-in Youn; Pingyan Cheng; David Quiceno; Dmitry I Gabrilovich
Journal:  Cancer Res       Date:  2012-01-11       Impact factor: 12.701

Review 6.  Suppression of antigen presentation by IL-10.

Authors:  Sharad K Mittal; Paul A Roche
Journal:  Curr Opin Immunol       Date:  2015-01-16       Impact factor: 7.486

7.  Essential role of IL-10/STAT3 in chronic stress-induced immune suppression.

Authors:  Dan Hu; Lei Wan; Michael Chen; Yi Caudle; Gene LeSage; Qinchuan Li; Deling Yin
Journal:  Brain Behav Immun       Date:  2014-02       Impact factor: 7.217

8.  Indirubin-3'-(2,3 dihydroxypropyl)-oximether (E804) is a potent modulator of LPS-stimulated macrophage functions.

Authors:  Abigail S Babcock; Amy L Anderson; Charles D Rice
Journal:  Toxicol Appl Pharmacol       Date:  2012-10-26       Impact factor: 4.219

9.  STAT3 promotes CD1d-mediated lipid antigen presentation by regulating a critical gene in glycosphingolipid biosynthesis.

Authors:  Abhirami K Iyer; Jianyun Liu; Richard M Gallo; Mark H Kaplan; Randy R Brutkiewicz
Journal:  Immunology       Date:  2015-09-21       Impact factor: 7.397

Review 10.  Anti-tumour strategies aiming to target tumour-associated macrophages.

Authors:  Xiaoqiang Tang; Chunfen Mo; Yongsheng Wang; Dandan Wei; Hengyi Xiao
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.